Is Celsius Holdings Stock a Buy Now?

Celsius Holdings (CELH) stock is showing signs of recovery after a significant decline in 2024, driven by a slowdown in demand; however, Q1 2025 revenue decreased 7% year-over-year to $329 million, and comprehensive income fell to $37 million from $63 million. While analysts forecast a 60% revenue increase in 2025 due to the Alani Nu acquisition, growth is expected to slow to 21% in 2026, making international expansion critical, where sales grew 41% annually and now represent 7% of revenue. Despite a high current P/E of 127, a forward P/E of 50 may better reflect its valuation, suggesting potential long-term gains contingent on international growth.

Analysis

Celsius Holdings (CELH) stock is attempting a recovery, up over 50% year-to-date after a more than 60% decline from its early 2024 peak, which was triggered by a major distributor, likely PepsiCo, scaling back orders due to sluggish demand. Despite this, quarterly revenues have surged by 75% since the PepsiCo distribution agreement in Q3 2022. Celsius has carved a niche targeting fitness enthusiasts, validated by clinical studies, and recently acquired Alani Nu in Q2 of this year, further bolstering its market presence where it holds an approximate 11% share. However, Q1 2025 financials showed a 7% year-over-year revenue decline to $329 million, a significant deceleration from the 102% growth in 2023, with comprehensive income concurrently falling to $37 million from $63 million in the year-ago quarter. The stock's current price-to-earnings (P/E) ratio is a high 127, though its forward P/E of 50, down from a peak of 125, is presented as a more reflective valuation metric as the company recovers from last year's slump. Analysts project 60% revenue growth in 2025, largely driven by the Alani Nu acquisition, followed by an expected slowdown to 21% revenue increase in 2026. The primary catalyst for sustained high growth is identified in international markets, which constituted 7% of Q1 2025 revenue, up from 4% year-over-year, and demonstrated robust 41% annual growth, indicating significant untapped potential.

Key Decisions for Investors

• Investors should carefully evaluate Celsius's high current P/E ratio of 127 against its more moderate forward P/E of 50, recognizing that near-term revenue growth is substantially supported by the Alani Nu acquisition rather than purely organic expansion.
• Closely monitor the progression of international sales, as their 41% annual growth and increasing contribution to total revenue (currently 7%) are pivotal for achieving long-term growth targets and justifying the stock's valuation beyond the initial post-acquisition surge.
• Acknowledge the forecasted moderation in revenue growth to 21% in 2026 and the stock's inherent volatility; while long-term prospects appear positive contingent on international success, near-term performance may be influenced by the integration of Alani Nu and the transition back to organic growth drivers.